$11.98
+0 (+0%)
At Close: Nov 26, 2025
Walgreens names Optum's Jason Stenta as chief commercial officer
08:52am, Monday, 07'th Oct 2024
Walgreens Boots Alliance named ex-Optum executive Jason Stenta as the company's chief commercial officer on Monday.
Walgreens: No Catalysts To Drive A Turnaround
09:31am, Thursday, 03'rd Oct 2024
In addition to weak consumer behavior and retail pharmacy industry headwinds, app downloads data suggests Walgreens is lagging vs. competition such as CVS. WBA has missed on margin expectations for mu
Wall Street's Most Accurate Analysts Spotlight On 3 Defensive Stocks Delivering High-Dividend Yields
07:33am, Thursday, 03'rd Oct 2024
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith reminds investors of the upcoming November 18, 2024 deadline to file a lead plaintiff motion in the case filed on behalf of investors who
Walgreens Announces New Student Loan 401(k) Match Program
10:00am, Wednesday, 02'nd Oct 2024
DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens, the leading independent retail pharmacy and healthcare provider, is announcing today the launch of the Walgreens Student Loan 401(k) Match Program. This ne
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, announces that a class action lawsuit has been filed on behalf of investors who p
2 Top Picks With Contrarian Potential as Q4 Looms
09:58am, Tuesday, 01'st Oct 2024
Subscribers to Chart of the Week received this commentary on Sunday, September 29.
Dividends Don't (Usually) Lie
12:27pm, Monday, 30'th Sep 2024
September 30, 2024 (Maple Hill Syndicate) – Geraldine Weiss, who died two years ago at age 96, was a successful investment newsletter writer at a time when few women were prominent in finance. She w
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Walgreens Boots Alliance, Inc. (WBA) Investors.
Walgreens: So Bad It's Good Heading Into Earnings (Rating Upgrade)
06:09pm, Sunday, 29'th Sep 2024
Walgreens (WBA) faces a challenging outlook with weak profit forecasts and negative EPS revisions, but technical signals suggest a potential upside, prompting a buy rating. Despite bearish trends and
Walgreens stock is cheap and oversold: is it a value trap?
02:19am, Saturday, 28'th Sep 2024
Walgreens Boots Alliance (WBA) has become a fallen angel, costing investors billions of dollars in the past few years. Its stock has imploded, falling from $69 in 2014 to $9 today, meaning that a $100
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Walgreens Boots Alliance, Inc. (“Walgreens”
5 Things You Need to Know If You Buy Walgreens Today
05:10am, Friday, 27'th Sep 2024
Walgreens stock is taking a hit, in part, because of prescription reimbursement pressures from insurers. Walgreens also made a poor acquisition that continues to weigh on its results.
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Walgreens Boo
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Walgreens Boots Alliance, Inc. (WBA) on Behalf of Investors
01:57pm, Thursday, 26'th Sep 2024
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Walgreens Boots Alliance, Inc. (“Walgreens” or the “Company”) (NASDAQ: WBA) investors con
Sign In
Buy WBA